153 related articles for article (PubMed ID: 27527686)
1. Clinical performance of transperineal template guided mapping biopsy for therapeutic decision making in low risk prostate cancer.
Ahallal Y; Sanchez-Salas R; Sivaraman A; Barret E; Secin FP; Validire P; Rozet F; Galiano M; Cathelineau X
Actas Urol Esp; 2016 Dec; 40(10):615-620. PubMed ID: 27527686
[TBL] [Abstract][Full Text] [Related]
2. Cancer Location in Upgrading and Detection after Transperineal Template-Guided Mapping Biopsy for Patients in Active Surveillance and Negative Transrectal Ultrasonography-Guided Prostate Biopsy.
Lee CU; Sung SH; Jang CT; Kang M; Sung HH; Jeong BC; Seo SI; Jeon SS; Lee HM; Jeon HG
Urol Int; 2019; 103(3):262-269. PubMed ID: 31269509
[TBL] [Abstract][Full Text] [Related]
3. Location and Grade of Prostate Cancer Diagnosed by Transperineal Template-guided Mapping Biopsy After Negative Transrectal Ultrasound-guided Biopsy.
Bittner N; Merrick G; Taira A; Bennett A; Schattel A; Butler W; Galbreath R; Adamovich E
Am J Clin Oncol; 2018 Aug; 41(8):723-729. PubMed ID: 27906722
[TBL] [Abstract][Full Text] [Related]
4. Transperineal Template-guided Mapping Biopsy Identifies Pathologic Differences Between Very-Low-risk and Low-risk Prostate Cancer: Implications for Active Surveillance.
Merrick GS; Delatore A; Butler WM; Bennett A; Fiano R; Anderson R; Adamovich E
Am J Clin Oncol; 2017 Feb; 40(1):53-59. PubMed ID: 25068472
[TBL] [Abstract][Full Text] [Related]
5. Transperineal template-guided mapping biopsy as a staging procedure to select patients best suited for active surveillance.
Taira AV; Merrick GS; Bennett A; Andreini H; Taubenslag W; Galbreath RW; Butler WM; Bittner N; Adamovich E
Am J Clin Oncol; 2013 Apr; 36(2):116-20. PubMed ID: 22307210
[TBL] [Abstract][Full Text] [Related]
6. Cribriform morphology predicts upstaging after radical prostatectomy in patients with Gleason score 3 + 4 = 7 prostate cancer at transrectal ultrasound (TRUS)-guided needle biopsy.
Keefe DT; Schieda N; El Hallani S; Breau RH; Morash C; Robertson SJ; Mai KT; Belanger EC; Flood TA
Virchows Arch; 2015 Oct; 467(4):437-42. PubMed ID: 26229020
[TBL] [Abstract][Full Text] [Related]
7. Diagnostic Performance of Initial Transperineal Template-guided Mapping Biopsy of the Prostate Gland.
Bittner N; Merrick GS; Bennett A; Butler WM; Andreini HJ; Taubenslag W; Adamovich E
Am J Clin Oncol; 2015 Jun; 38(3):300-3. PubMed ID: 23764680
[TBL] [Abstract][Full Text] [Related]
8. Obesity does not correlate with adverse pathologic findings on transperineal template-guided mapping biopsy of the prostate.
Bittner N; Merrick GS; Stewart R; Andreini H; Taubenslag W; Curtis R; Butler WM; Wallner KE
Urol Oncol; 2011; 29(4):398-404. PubMed ID: 19945303
[TBL] [Abstract][Full Text] [Related]
9. Incidence, grade and distribution of prostate cancer following transperineal template-guided mapping biopsy in patients with atypical small acinar proliferation.
Merrick GS; Galbreath RW; Bennett A; Butler WM; Amamovich E
World J Urol; 2017 Jul; 35(7):1009-1013. PubMed ID: 27900453
[TBL] [Abstract][Full Text] [Related]
10. Incidence and pathological features of prostate cancer detected on transperineal template guided mapping biopsy after negative transrectal ultrasound guided biopsy.
Bittner N; Merrick GS; Butler WM; Bennett A; Galbreath RW
J Urol; 2013 Aug; 190(2):509-14. PubMed ID: 23416641
[TBL] [Abstract][Full Text] [Related]
11. Active surveillance outcomes in prostate cancer patients: the use of transperineal template-guided mapping biopsy for patient selection.
Merrick GS; Tennant A; Fiano R; Bennett A; Anderson R; Galbreath R; Butler WM; Adamovich E
World J Urol; 2020 Feb; 38(2):361-369. PubMed ID: 31020423
[TBL] [Abstract][Full Text] [Related]
12. Combination of multiparametric MRI and transperineal template-guided mapping biopsy of the prostate to identify candidates for hemi-ablative focal therapy.
Tran M; Thompson J; Böhm M; Pulbrook M; Moses D; Shnier R; Brenner P; Delprado W; Haynes AM; Savdie R; Stricker PD
BJU Int; 2016 Jan; 117(1):48-54. PubMed ID: 25682968
[TBL] [Abstract][Full Text] [Related]
13. Performance of transperineal template-guided mapping biopsy in detecting prostate cancer in the initial and repeat biopsy setting.
Taira AV; Merrick GS; Galbreath RW; Andreini H; Taubenslag W; Curtis R; Butler WM; Adamovich E; Wallner KE
Prostate Cancer Prostatic Dis; 2010 Mar; 13(1):71-7. PubMed ID: 19786982
[TBL] [Abstract][Full Text] [Related]
14. The clinical utility of transperineal template-guided saturation prostate biopsy for risk stratification after transrectal ultrasound-guided biopsy.
Song W; Kang M; Jeong BC; Seo SI; Jeon SS; Lee HM; Jeon HG
Investig Clin Urol; 2019 Nov; 60(6):454-462. PubMed ID: 31692988
[TBL] [Abstract][Full Text] [Related]
15. Transperineal Template Guided Prostate Biopsy Selects Candidates for Active Surveillance--How Many Cores are Enough?
Pham KN; Porter CR; Odem-Davis K; Wolff EM; Jeldres C; Wei JT; Morgan TM
J Urol; 2015 Sep; 194(3):674-9. PubMed ID: 25963186
[TBL] [Abstract][Full Text] [Related]
16. The morbidity of transperineal template-guided prostate mapping biopsy.
Merrick GS; Taubenslag W; Andreini H; Brammer S; Butler WM; Adamovich E; Allen Z; Anderson R; Wallner KE
BJU Int; 2008 Jun; 101(12):1524-9. PubMed ID: 18325064
[TBL] [Abstract][Full Text] [Related]
17. Utility of early transperineal template-guided prostate biopsy for risk stratification in men undergoing active surveillance for prostate cancer.
Voss J; Pal R; Ahmed S; Hannah M; Jaulim A; Walton T
BJU Int; 2018 Jun; 121(6):863-870. PubMed ID: 29239082
[TBL] [Abstract][Full Text] [Related]
18. Transperineal biopsy prostate cancer detection in first biopsy and repeat biopsy after negative transrectal ultrasound-guided biopsy: the Victorian Transperineal Biopsy Collaboration experience.
Ong WL; Weerakoon M; Huang S; Paul E; Lawrentschuk N; Frydenberg M; Moon D; Murphy D; Grummet J
BJU Int; 2015 Oct; 116(4):568-76. PubMed ID: 25560926
[TBL] [Abstract][Full Text] [Related]
19. Unilateral positive biopsies in low risk prostate cancer patients diagnosed with extended transrectal ultrasound-guided biopsy schemes do not predict unilateral prostate cancer at radical prostatectomy.
Gallina A; Maccagnano C; Suardi N; Capitanio U; Abdollah F; Raber M; Salonia A; Scattoni V; Rigatti P; Montorsi F; Briganti A
BJU Int; 2012 Jul; 110(2 Pt 2):E64-8. PubMed ID: 22093108
[TBL] [Abstract][Full Text] [Related]
20. A Comprehensive Assessment of the Utility of Transperineal Template Prostate Mapping Biopsy: A 13-year Experience.
Michael ZD; Kotamarti S; Deivasigamani S; Seguier D; Polascik TJ
Urology; 2023 Jul; 177():115-121. PubMed ID: 37105359
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
